Cancer Research UK logo.
SearchDonate
  • Search

A study looking at a targeted treatment for glioblastoma (CITADEL-123)

Overview

Cancer types:

Brain (and spinal cord) tumours

Status:

Open

Phase:

Phase 1

Details

This study is looking at a targeted treatment called 123I-ATT001 for a type of brain tumour called that has come back after treatment.

Recruitment start: 4 July 2024

Recruitment end: 30 October 2025

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Paul Mulholland

Supported by

Theragnostics Limited, an Ariceum company

Last reviewed: 28 January 2025

CRUK internal database number: 19962

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.